During the short term, economic softness will continue to restrain procedure growth in the U.S. due to the postponement of hip and knee replacement surgeries. Trends in product mix, such as the shift away from metal-on-metal total hip replacement devices, will affect selling prices and revenues, and healthcare reform efforts should help to spur procedures later in the forecast period. The European market will be sustained by greater demand for hip and knee replacement technologies in Eastern European countries as well as positive demographical factors in countries such as France, Germany, Italy, Spain, and the United Kingdom. Sales of large joint replacement products in the Asia-Pacific region and elsewhere in the world should increase rapidly due to growing penetration in China and other emerging markets.
This report examines the market for replacement and resurfacing products for the hips and knees, and provides a detailed analysis of the clinical and economic factors driving markets around the world.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
